74
Participants
Start Date
January 12, 2022
Primary Completion Date
March 30, 2024
Study Completion Date
June 1, 2024
Placebo treatment
Active drug/placebo is handed out equivalent of 1 tablet of 0,2 mg Naldemedine or placebo daily for 365 days.
Naldemedine 0.2 MG Oral Tablet
Active drug/placebo is handed out equivalent of 1 tablet of 0,2 mg Naldemedine or placebo daily for 365 days.
Mech-Sense, Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg
Digestive Disease Center K, Bispebjerg University Hospital, Bispebjerg
Gastrounit, Hvidovre University Hospital, Hvidovre
Odense Pancreas Center, Svendborg
Karolinska University Hospital, Stockholm
Odense University Hospital
OTHER
Hvidovre University Hospital
OTHER
University Hospital Bispebjerg and Frederiksberg
OTHER
Karolinska University Hospital
OTHER
Asbjørn Mohr Drewes
OTHER